[Federal Register Volume 70, Number 88 (Monday, May 9, 2005)]
[Notices]
[Page 24449]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-9228]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Drug Safety and Risk Management Advisory Committee; Amendment of 
Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Drug Safety and Risk Management 
Advisory Committee. This meeting was announced in the Federal Register 
of April 14, 2005 (70 FR 19763). The amendment is being made to reflect 
a change in the Date and Time portion of the document. The start time 
for each day of the meeting will be changed. There are no other 
changes.

FOR FURTHER INFORMATION CONTACT: Shalini Jain, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: 
[email protected], or FDA Advisory Committee Information Line, 1-800-
741-8138 (301-443-0572 in the Washington DC area), code 3014512535. 
Please call the Information Line for up-to-date information on this 
meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of April 14, 2005, 
FDA announced that a meeting of the Drug Safety and Risk Management 
Advisory Committee would be held on May 18 and 19, 2005, from 8:30 a.m. 
to 5 p.m. On page 19763, in the third column, the Date and Time portion 
of the meeting notice is amended to read as follows:
    Date and Time: The meeting will be held on May 18 and 19, 2005, 
from 8 a.m. to 5 p.m.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: May 3, 2005.
Lester M. Crawford,
Acting Commissioner of Food and Drugs.
[FR Doc. 05-9228 Filed 5-6-05; 8:45 am]
BILLING CODE 4160-01-S